LEVETIRACETAM DEXCEL 1000

Land: Israel

Sprache: Englisch

Quelle: Ministry of Health

Wirkstoff:

LEVETIRACETAM

Verfügbar ab:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-Code:

N03AX14

Darreichungsform:

TABLETS

Zusammensetzung:

LEVETIRACETAM 1000 MG

Verabreichungsweg:

PER OS

Verschreibungstyp:

Required

Hergestellt von:

DEXCEL LTD, ISRAEL

Therapiegruppe:

LEVETIRACETAM

Therapiebereich:

LEVETIRACETAM

Anwendungsgebiete:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Berechtigungsdatum:

2018-03-31